Home > Qtrly Results > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
Quarterly Results Analysis [Sep2025]

AD     Remove this Ad

SAMRAT PHARMACHEM Quarterly Results

Standalone Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Revenues ₹79 Cr ₹76 Cr ₹71 Cr ₹64 Cr ₹70 Cr ₹81 Cr ₹83 Cr ₹62 Cr
Expenses ₹79 Cr ₹76 Cr ₹71 Cr ₹59 Cr ₹67 Cr ₹78 Cr ₹81 Cr ₹62 Cr
Operating Income ₹0 Cr ₹0 Cr ₹0 Cr ₹4 Cr ₹3 Cr ₹3 Cr ₹1 Cr ₹0 Cr
Other Income ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Profit Before Tax ₹-1 Cr ₹0 Cr ₹0 Cr ₹4 Cr ₹4 Cr ₹3 Cr ₹1 Cr ₹0 Cr
Profit After Tax ₹-1 Cr ₹0 Cr ₹0 Cr ₹3 Cr ₹3 Cr ₹2 Cr ₹1 Cr ₹0 Cr
EPS ₹-1.90 ₹-0.74 ₹-1.29 ₹9.01 ₹8.61 ₹6.69 ₹4.51 ₹1.11
Industry Peers & Returns1W1M1Y
SAMRAT PHARMACHEM 12.3% 10.5% -32.9%
SUN PHARMACEUTICAL INDUSTRIES 0.2% -1.3% -3.5%
DIVIS LABORATORIES 1.9% -6.7% 0.4%
CIPLA 1.3% -8.5% -7.3%
TORRENT PHARMACEUTICALS 1.3% 2.9% 28.7%
DR REDDYS LABORATORIES 1.3% 3.8% 4.5%
MANKIND PHARMA -0.9% -5.8% -18.4%
ZYDUS LIFESCIENCES -2% -0.9% -5.2%
LUPIN 0.5% 1.1% 4.2%

SAMRAT PHARMACHEM Quarterly Revenues

Revenues
Q-o-Q

4.25 %

Y-o-Y

12.40 %

Quarters Revenues % Change
Sep2025 ₹79 Cr
4.25
Jun2025 ₹76 Cr
6.25
Mar2025 ₹71 Cr
11.85
Dec2024 ₹64 Cr
-9.28
Sep2024 ₹70 Cr
-13.18
Jun2024 ₹81 Cr
-2.25
Mar2024 ₹83 Cr
34.06
Dec2023 ₹62 Cr -

SAMRAT PHARMACHEM Quarterly Operating Profit

Operating Profit
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Operating Profit % Change
Sep2025 ₹0 Cr
Negative
Jun2025 ₹0 Cr
-0.79
Mar2025 ₹0 Cr
-96.98
Dec2024 ₹4 Cr
24.17
Sep2024 ₹3 Cr
29.94
Jun2024 ₹3 Cr
90.63
Mar2024 ₹1 Cr
1,100.00
Dec2023 ₹0 Cr -
Operating Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Operating Margin% % Change
Sep2025 -0.46%
Negative
Jun2025 0.17%
-5.56
Mar2025 0.18%
-97.25
Dec2024 6.55%
36.74
Sep2024 4.79%
49.69
Jun2024 3.2%
95.12
Mar2024 1.64%
811.11
Dec2023 0.18% -

SAMRAT PHARMACHEM Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Sep2025 ₹-1 Cr
Negative
Jun2025 ₹0 Cr
Negative
Mar2025 ₹0 Cr
Negative
Dec2024 ₹3 Cr
4.66
Sep2024 ₹3 Cr
28.80
Jun2024 ₹2 Cr
48.10
Mar2024 ₹1 Cr
305.52
Dec2023 ₹0 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Sep2025 -0.75 %
Negative
Jun2025 -0.3 %
Negative
Mar2025 -0.56 %
Negative
Dec2024 4.37 %
15.30
Sep2024 3.79 %
48.05
Jun2024 2.56 %
51.48
Mar2024 1.69 %
201.79
Dec2023 0.56 % -

SAMRAT PHARMACHEM Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Sep2025 ₹-1.9
Negative
Jun2025 ₹-0.74
Negative
Mar2025 ₹-1.29
Negative
Dec2024 ₹9.01
4.65
Sep2024 ₹8.61
28.70
Jun2024 ₹6.69
48.34
Mar2024 ₹4.51
306.31
Dec2023 ₹1.11 -

You may also like the below Video Courses